Articles
Feature: Next next generation sequencing
It took nearly two decades to go from the release of the first semi-automated genome sequencer in the mid-1980s to the launch of Roche's flagship 454 FLX next generation sequencer in 2005. The 454 is now one of three major players in the next gen market whose impact on the world of genomics cannot be underestimated. Just five years later we are poised to embrace the next generation of sequencing technology. [ + ]
The mathematics of fat cell formation
Scientists using mathematics to try to determine what causes the birth of a human fat cell have come up with a few predictions about the proteins that influence this process.
[ + ]Aspen to buy Sigma Pharmaceuticals' drug division for $900m
Troubled drug developer and healthcare provider Sigma Pharmaceuticals finally put an end to months of speculation today declaring that it would recommend shareholders accept an offer from Aspen Pharmacare to buy its pharmaceuticals business for $900 million. [ + ]
Cochlear reports record full year results
Cochlear released its full year results today reporting a 19 percent increase in net profit to $155.2 million on the back of record total revenues of $784.8 million. [ + ]
Feature: Automating the personalised medicine revolution
Processing large numbers of samples rapidly is going to be crucial if the vision of personalised medicine is ever going to become a reality. [ + ]
Want a career in science? Good at maths? Bioinformatics needs you!
The staggering amounts of data being generated in genomics, epigenomics, proteomics and other ‘omics studies - not to mention systems biology, which attempts to knit the various ‘omics together - is presenting a titanic challenge for life science researchers. [ + ]
Do you see what I see?
An important new link between what people see and the way their minds process that visual information has been discovered.
[ + ]New study to turn cancer research on its head
Researchers at the Walter and Eliza Hall Institute (WEHI) have shown that programmed cell death or apoptosis, a process which has typically been assumed to prevent or slow the development of cancer, may in some instances contribute to its spreading. [ + ]
BioWhittaker X-VIVO media systems
Lonza’s R&D efforts and collaboration with many clinical trials have provided Lonza with the tools and expertise to support the developments in adoptive immunotherapy, cancer therapy, genetic therapy and other cellular therapies.
[ + ]Missing Puma reveals cancer conundrum
Walter and Eliza Hall Institute researchers have made a discovery that has upended scientists’ understanding of programmed cell death and its role in tumour formation.
[ + ]Illumina Announces New TruSeq SBS Sequencing Kit for the Genome Analyzer
Illumina today announced the launch of its TruSeq SBS Sequencing kit that will enable high-quality paired end reads of 150 base pairs (bp), increase the output of high-quality base calls, and enhance throughput to greater than 95 Gigabases (Gb) of high-quality base pairs per run on Illumina's Genome Analyzer (GA) sequencing system. [ + ]
Causes of gluten intolerance discovered
Researchers at the Walta and Eliza Hall Institute (WEHI) reported today that they have found the three key protein fragments in gluten that cause an immune response in those with coeliac disease. [ + ]
Studies reveal iPS cells stay true to their roots
Two research groups connected with the Harvard Stem Cell Institute this week published the results of studies which highlight crucial differences between embryonic and induced pluripotent stem iPS cells. [ + ]